Cook Steven L. sold $28K of OMDA

Omada Health (OMDA) reported Q2 2026 revenue of $88 million, up 43% year over year, with GAAP gross margin of 73% and GAAP net income of $5 million. Adjusted EBITDA was $11 million. The company raised full-year revenue guidance to $334 million to $340 million and adjusted EBITDA to $21 million to $27 million, citing member growth and lower cost to serve.

Omada Health, which went public in June, said Wei-Li Shao will become CEO on Jan. 1, replacing founder Sean Duffy, who will move to executive chair. The change was announced with Q2 results. Omada reported Q2 revenue of $88 million (+43% Y/Y), profit of $5 million, gross margin of 73%, and raised 2026 revenue guidance to $334 million-$340 million.

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Become Executive Chair and Wei-Li Shao to Become Ch

DE ANGOITIA ALFONSO purchased 476,190 indirectly-held shares of Liberty Latin America Ltd. (LILA) at an average of $20.95 ($20.65–$21.00, $9.98M total) across 3 trades over 2026-08-31 to 2026-09-02.

Meister Keith A. sold 263,560 indirectly-held shares of ILLUMINA, INC. (ILMN) at an average of $217.03 ($213.20–$221.55, $57.20M total) across 12 trades over 2026-09-02 to 2026-09-04.

Spetzler David Baxley (President) sold 597,212 shares of Caris Life Sciences, Inc. (CAI) at an average of $24.84 ($24.76–$25.32, $14.83M total) across 3 trades over 2026-09-03 to 2026-09-04.